$13.34
-0.25-1.84%
al cierre: -
$13.36
0.020.15%
After hour: 7:08 PM EDT
10x Genomics emite una orientación sobre las ganancias por acción y los ingresos futuros, lo que ofrece a los inversores una idea de cuánto espera ganar la empresa en los próximos períodos.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
08/07/2025 | TXG | 10x Genomics | Q3 | 2025 | — | — | — | $140.00M | $144.00M | $139.48M | |
05/08/2025 | TXG | 10x Genomics | Q2 | 2025 | — | — | — | $138.00M | $142.00M | $145.59M | |
02/12/2025 | TXG | 10x Genomics | FY | 2025 | — | — | — | $610.00M | $630.00M | $630.36M | |
01/13/2025 | TXG | 10x Genomics | FY | 2024 | — | — | — | $611.00M | $611.00M | $610.80M | |
10/29/2024 | TXG | 10x Genomics | FY | 2024 | — | — | — | $595.00M | $605.00M | $636.59M | |
10/09/2024 | TXG | 10x Genomics | Q3 | 2024 | — | — | — | $151.70M | $151.70M | $162.24M | |
08/08/2024 | TXG | 10x Genomics | FY | 2024 | — | — | — | $640.00M | $660.00M | $663.06M | |
04/30/2024 | TXG | 10x Genomics | FY | 2024 | — | — | — | $670.00M | $690.00M | $677.79M | |
02/15/2024 | TXG | 10x Genomics | FY | 2024 | — | — | — | $670.00M | $690.00M | $702.06M | |
01/08/2024 | TXG | 10x Genomics | FY | 2023 | — | — | — | $618.70M | $618.70M | $614.69M | |
01/08/2024 | TXG | 10x Genomics | Q4 | 2023 | — | — | — | $184.00M | $184.00M | $179.70M | |
11/02/2023 | TXG | 10x Genomics | FY | 2023 | — | — | — | $610.00M | $625.00M | $608.22M | |
08/03/2023 | TXG | 10x Genomics | FY | 2023 | — | — | — | $600.00M | $620.00M | $600.73M | |
05/03/2023 | TXG | 10x Genomics | FY | 2023 | — | — | — | $590.00M | $610.00M | $593.20M | |
02/15/2023 | TXG | 10x Genomics | FY | 2023 | — | — | — | $580.00M | $600.00M | $613.96M | |
11/02/2022 | TXG | 10x Genomics | FY | 2022 | — | — | — | $500.00M | $520.00M | $509.87M | |
08/08/2022 | TXG | 10x Genomics | FY | 2022 | — | — | — | $500.00M | $520.00M | $571.06M | |
07/14/2022 | TXG | 10x Genomics | Q2 | 2022 | — | — | — | $114.50M | $114.50M | $127.70M | |
05/04/2022 | TXG | 10x Genomics | FY | 2022 | — | — | — | $600.00M | $630.00M | $614.05M | |
02/16/2022 | TXG | 10x Genomics | FY | 2022 | — | — | — | $600.00M | $630.00M | $679.87M | |
11/03/2021 | TXG | 10x Genomics | FY | 2021 | — | — | — | $490.00M | $500.00M | $489.77M | |
08/04/2021 | TXG | 10x Genomics | FY | 2021 | — | — | — | $480.00M | $500.00M | $496.49M | |
05/05/2021 | TXG | 10x Genomics | FY | 2021 | — | — | — | $480.00M | $500.00M | $494.98M | |
02/17/2021 | TXG | 10x Genomics | FY | 2021 | — | — | — | $480.00M | $500.00M | $494.02M |
En los últimos meses no se han comunicado orientaciones específicas de ventas o beneficios para 10x Genomics.
Explora orientación y previsión sobre todos los valores.